Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 14.290 | 14.290 | 0.000 |
Stocks | 87.810 | 87.810 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.051 | 24.124 |
Price to Book | 2.146 | 3.013 |
Price to Sales | 0.962 | 3.867 |
Price to Cash Flow | 11.966 | 15.880 |
Dividend Yield | 3.099 | 1.889 |
5 Years Earnings Growth | 10.430 | 13.292 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.380 | 95.436 |
Consumer Cyclical | 2.620 | 1.238 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shenzhen Mindray Bio-Medical | CNE100003G67 | 9.89 | 241.30 | -1.71% | |
Jiangsu Hengrui | CNE0000014W7 | 8.51 | 44.04 | -2.16% | |
Jointown Pharm | CNE100000W45 | 7.23 | 4.96 | -2.17% | |
Humanwell Healthcare | CNE000000QW6 | 5.99 | 21.35 | -0.14% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 5.14 | 16.24 | -1.52% | |
WuXi AppTec | CNE1000031K4 | 4.83 | 52.38 | -0.98% | |
Nhwa Pharma A | CNE100000CG8 | 4.27 | 22.62 | -5.00% | |
New Industries | CNE100003T39 | 2.93 | 64.91 | -2.21% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 2.72 | 25.34 | -0.90% | |
Yunnan Baiyao A | CNE0000008X7 | 2.58 | 57.58 | -0.84% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 607.16M | -5.89 | -10.83 | 4.33 | ||
MS Huaxin Resource Selected Mixed | 449.42M | 12.77 | -17.82 | 3.53 | ||
MS Huaxin Aggressive Growth Equity | 375.88M | 3.52 | -13.21 | 4.92 | ||
Huaxin Leading Advanced Stock | 311.33M | 1.63 | -11.19 | 7.46 | ||
MS Huaxin Quality Life Sec inv | 283.97M | 4.95 | -10.63 | 10.73 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review